Fundies.
English

Agile Therapeutics, Inc.

EDGAR
AGRX Quarterly report (10-Q) · filed 2024-08-12

137 filing records in this dataset, filed from 2014-03-17 to 2024-08-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

5.58 million Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ

2024 Q2 · Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ

Exact inputs and evidence
  • Revenue: 5576000 Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ Source

Operating margin

-49.25%

2024 Q2 · %

Exact inputs and evidence
  • Operating Income: -2746000 Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ Source
  • Revenue: 5576000 Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ Source
Cash and cash equivalents
2.85 million Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ Source
Exact value

2848000 Unit_Standard_USD_crpe_D-wyk2gD2JO8LmLxQ

Long-term debt including current maturities
Not available
Shares outstanding
6.9 million Unit_Standard_shares_uTeyHvXOhkmtzWsZZkHGVw Source
Exact value

6904498 Unit_Standard_shares_uTeyHvXOhkmtzWsZZkHGVw

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-08-12.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2023-12-31
  • Operating income: 3 of 11 periods available· newest 2023-12-31
  • Net income: 3 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2023-12-31
  • Capital expenditure: Multiple units; comparison withheld· newest 2022-12-31
  • Total assets: Multiple units; comparison withheld· newest 2023-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2023-12-31
  • Current assets: Multiple units; comparison withheld· newest 2023-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2023-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2023-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2023-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +80%

    Prior period

    Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 10.88 million

    –

    Current period

    Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 19.59 million

    –

    Exact inputs and evidence

    19593000 − 10884000 = 8709000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

    10884000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    19593000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 10.95 million

    Prior period

    −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 25.41 million

    –

    Current period

    −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 14.47 million

    –

    Exact inputs and evidence

    -14465000 − -25412000 = 10947000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

    -25412000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -14465000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 26.37 million

    Prior period

    −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 35.95 million

    –

    Current period

    −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 9.58 million

    –

    Exact inputs and evidence

    -9577000 − -35947000 = 26370000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

    -35947000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -9577000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 19.59 million 100% of revenue
  • Cost of revenue Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 8.98 million 46% of revenue
  • Operating expenses Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 30.5 million 156% of revenue
  • Operating income −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 19.88 million −101% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 5.42 million −28% of revenue
  • Net income −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 14.47 million −74% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 9.58 million −49% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Operating loss: operating costs were 1,831% of revenue.
  • 2022 Operating loss: operating costs were 583% of revenue.
  • 2023 Operating loss: operating costs were 201% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-314101000 75106000 Derived -71005000 62000 Derived -71067000 Unavailable
Source
2022 2022-01-01 – 2022-12-3110884000 63440000 Derived -52556000 -27144000 Derived -25412000 Unavailable
Source
2023 2023-01-01 – 2023-12-3119593000 39477000 Derived -19884000 -5419000 Derived -14465000 Unavailable
Source

Amounts are exact, in Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 19.6M 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.21.2M15.9M10.6M5.3M0.0202120222023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA)Source evidence
2021Revenue4101000
2022Revenue10884000
2023Revenue19593000

Revenue growth

Change in revenue from the same financial period one year earlier.

80% 2023
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.179%134%89%45%0%202120222023
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over year165.4%
2023Year over year80%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -101.5% 2023
Net margin -73.8% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.139%-364%-866%-1,369%-1,872%202120222023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating margin-1,731.4%
2022Operating margin-482.9%
2023Operating margin-101.5%
2021Net margin-1,732.9%
2022Net margin-233.5%
2023Net margin-73.8%
2021Free cash flow marginNot reported
2022Free cash flow marginNot reported
2023Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA -9.6M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.2M-13.7M-32.6M-51.5M-70.4M202120222023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA)Source evidence
2021Operating cash flow-65202000
2022Operating cash flow-35947000
2023Operating cash flow-9577000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA)Source evidence
2021Free cash flowUnavailable
2022Free cash flowUnavailable
2023Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021-12-31Liabilities / assetsNot reportedNo source recorded
2022-12-31Liabilities / assetsNot reportedNo source recorded
2023-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021-12-31Current assets / current liabilitiesNot reportedNo source recorded
2022-12-31Current assets / current liabilitiesNot reportedNo source recorded
2023-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-01 – 2021-12-31
−Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 71.07 million
Exact value

Exact value: -71067000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

2021-01-01 – 2021-12-31: -71067000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 65.2 million
Exact value

Exact value: -65202000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

2021-01-01 – 2021-12-31: -65202000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 25.41 million
Exact value

Exact value: -25412000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

2022-01-01 – 2022-12-31: -25412000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 35.95 million
Exact value

Exact value: -35947000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

2022-01-01 – 2022-12-31: -35947000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 14.47 million
Exact value

Exact value: -14465000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

2023-01-01 – 2023-12-31: -14465000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA 9.58 million
Exact value

Exact value: -9577000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA

2023-01-01 – 2023-12-31: -9577000 Unit_Standard_USD_w0lfWS7fp0K7nByrNPBspA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

137 filings · 4,099 latest values · 4,099 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001261249, 1261249, AGRX, edgar:1261249

Also known as AGILE THERAPEUTICS INC, Agile Therapeutics, Inc.